E3 PreliminaryPreliminaryPEM unclearPeer-reviewedMachine draft
Reversal of Refractory Ulcerative Colitis and Severe Chronic Fatigue Syndrome Symptoms Arising from Immune Disturbance in an HLA-DR/DQ Genetically Susceptible Individual with Multiple Biotoxin Exposures.
Gunn, Shelly R, Gunn, G Gibson, Mueller, Francis W · The American journal of case reports · 2016 · DOI
Quick Summary
This case report describes one 25-year-old man who had both severe inflammatory bowel disease and chronic fatigue syndrome that improved dramatically after identifying and removing mold exposure from his home, receiving a hormone replacement therapy (VIP), and doing stress-reduction exercises. The patient's genetic makeup made him more susceptible to problems when exposed to toxic mold, and treating the underlying immune disturbance resolved his symptoms without medication.
Why It Matters
This case suggests that in genetically susceptible individuals, ME/CFS symptoms may overlap with or arise from biotoxin-related immune dysregulation, opening an alternative investigative pathway for a subset of patients. The potential reversibility of severe symptoms highlights the importance of considering environmental and immune biomarker assessment in refractory cases, even when standard autoimmune workups are negative.
Observed Findings
- Positive urine mycotoxin panel (trichothecene group) and identification of Stachybotrys chartarum in home air filters
- Multisusceptible HLA-DR/DQ haplotype and elevated serum TGF-beta with clinically undetectable VIP levels
- Negative autoimmune disease biomarkers despite severe symptoms of ulcerative colitis and chronic fatigue
- Complete symptom resolution following mold remediation, VIP replacement therapy, dental extractions, and stress-reduction program
- Return to work and normal exercise without medications
Inferred Conclusions
- Biotoxin exposure in genetically susceptible (HLA-DR/DQ) individuals may trigger chronic immune dysregulation consistent with CIRS pathophysiology
- CIRS biomarkers (elevated TGF-beta, suppressed VIP) may identify a treatable underlying etiology in a subset of patients with RUC and CFS
- Multidimensional treatment addressing biotoxin elimination, immune modulation, and stress response may resolve refractory symptoms in susceptible individuals
Remaining Questions
- How common is biotoxin exposure and CIRS-pattern immune dysregulation among the broader ME/CFS patient population?
- Which specific intervention (mold remediation, VIP replacement, dental work, or stress reduction) was necessary and sufficient for symptom resolution?
What This Study Does Not Prove
This single case report cannot establish that biotoxin exposure causes ME/CFS in the broader patient population, nor does it prove that VIP replacement or mold remediation will benefit other patients. The temporal relationship between interventions and symptom resolution does not prove causation, and the simultaneous implementation of multiple treatments makes it impossible to identify which intervention(s) were actually responsible for improvement.
Tags
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only
Metadata
- DOI
- 10.12659/ajcr.896949
- PMID
- 27165859
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →